Your browser doesn't support javascript.
loading
Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease.
Le Guen, Yann; Belloy, Michael E; Grenier-Boley, Benjamin; de Rojas, Itziar; Castillo-Morales, Atahualpa; Jansen, Iris; Nicolas, Aude; Bellenguez, Céline; Dalmasso, Carolina; Küçükali, Fahri; Eger, Sarah J; Rasmussen, Katrine Laura; Thomassen, Jesper Qvist; Deleuze, Jean-François; He, Zihuai; Napolioni, Valerio; Amouyel, Philippe; Jessen, Frank; Kehoe, Patrick G; van Duijn, Cornelia; Tsolaki, Magda; Sánchez-Juan, Pascual; Sleegers, Kristel; Ingelsson, Martin; Rossi, Giacomina; Hiltunen, Mikko; Sims, Rebecca; van der Flier, Wiesje M; Ramirez, Alfredo; Andreassen, Ole A; Frikke-Schmidt, Ruth; Williams, Julie; Ruiz, Agustín; Lambert, Jean-Charles; Greicius, Michael D; Arosio, Beatrice; Benussi, Luisa; Boland, Anne; Borroni, Barbara; Caffarra, Paolo; Daian, Delphine; Daniele, Antonio; Debette, Stéphanie; Dufouil, Carole; Düzel, Emrah; Galimberti, Daniela; Giedraitis, Vilmantas; Grimmer, Timo; Graff, Caroline; Grünblatt, Edna.
Afiliação
  • Le Guen Y; Department of Neurology and Neurological Sciences, Stanford University, Palo Alto, California.
  • Belloy ME; Institut du Cerveau, Paris Brain Institute, Paris, France.
  • Grenier-Boley B; Department of Neurology and Neurological Sciences, Stanford University, Palo Alto, California.
  • de Rojas I; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1167-RID-AGE Facteurs de risque et déterminants moléculaires des maladies liées au vieillissement, Lille, France.
  • Castillo-Morales A; Research Center and Memory Clinic Fundació ACE, Institut Català de Neurociències Aplicades, Universitat Internacional de Catalunya, Barcelona, Spain.
  • Jansen I; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
  • Nicolas A; UKDRI@Cardiff, School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • Bellenguez C; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.
  • Dalmasso C; Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Vrije University, Amsterdam, the Netherlands.
  • Küçükali F; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1167-RID-AGE Facteurs de risque et déterminants moléculaires des maladies liées au vieillissement, Lille, France.
  • Eger SJ; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1167-RID-AGE Facteurs de risque et déterminants moléculaires des maladies liées au vieillissement, Lille, France.
  • Rasmussen KL; Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Thomassen JQ; Estudios en Neurociencias y Sistemas Complejos (ENyS) CONICET-HEC-UNAJ, Universidad Nacional Arturo Jauretche, Florencio Varela, Argentina.
  • Deleuze JF; Complex Genetics of Alzheimer's Disease Group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium.
  • He Z; Laboratory of Neurogenetics, Born-Bunge Institute, Antwerp, Belgium.
  • Napolioni V; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
  • Amouyel P; Department of Neurology and Neurological Sciences, Stanford University, Palo Alto, California.
  • Jessen F; Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Kehoe PG; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • van Duijn C; Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Tsolaki M; Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, Evry, France.
  • Sánchez-Juan P; Department of Neurology and Neurological Sciences, Stanford University, Palo Alto, California.
  • Sleegers K; Quantitative Sciences Unit, Department of Medicine, Stanford University, Palo Alto, California.
  • Ingelsson M; School of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy.
  • Rossi G; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1167-RID-AGE Facteurs de risque et déterminants moléculaires des maladies liées au vieillissement, Lille, France.
  • Hiltunen M; Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Sims R; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • van der Flier WM; Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
  • Ramirez A; Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
  • Andreassen OA; Department of Epidemiology, ErasmusMC, Rotterdam, the Netherlands.
  • Frikke-Schmidt R; Nuffield Department of Population Health Oxford University, Oxford, United Kingdom.
  • Williams J; 1st Department of Neurology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Ruiz A; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
  • Lambert JC; Alzheimer's Centre Reina Sofia-CIEN Foundation, Madrid, Spain.
  • Greicius MD; Complex Genetics of Alzheimer's Disease Group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium.
  • Arosio B; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
  • Benussi L; Department of Public Health and Caring Sciences / Geriatrics, Uppsala University, Uppsala, Sweden.
  • Boland A; Krembil Brain Institute, University Health Network, Toronto, Ontario, Canada.
  • Borroni B; Department of Medicine and Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada.
  • Caffarra P; Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Daian D; Institute of Biomedicine, University of Eastern Finland, Joensuu, Kuopio, Finland.
  • Daniele A; Division of Psychological Medicine and Clinical Neuroscience, School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • Debette S; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.
  • Dufouil C; Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Düzel E; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Galimberti D; Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
  • Giedraitis V; Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.
  • Grimmer T; Department of Psychiatry and Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, UT Health San Antonio, The University of Texas Health Science Center at San Antonio.
  • Graff C; NORMENT Centre, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Grünblatt E; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
JAMA Neurol ; 79(7): 652-663, 2022 07 01.
Article em En | MEDLINE | ID: mdl-35639372
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Idioma: En Ano de publicação: 2022 Tipo de documento: Article